Latin America Protein Chip Market is segmented By Technology (Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays), By Application (Diagnostics, Proteomics, Antibody Characterization), By End-User (Hospital & Clinics, Diagnostic Laboratories, Academic & Research Institutes, Pharmaceuticals & Biotechnological Companies), and By Country (Brazil, Argentina, Chile, Mexico and Rest of Latin America) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030
Latin America Protein Chip Market Overview
The Latin America Protein Chip Market is expected to grow at a CAGR of 18.1% during the forecast period 2023-2030.
Protein microarrays, also known as protein chips, are high-density parallel assay systems containing small amounts of proteins. Protein chips play an important function in diagnostics. With the help of these chips, healthcare providers can check the level of infection for a particular disease or disorder.
Protein chips have been extensively employed in healthcare and biological industries to conduct fundamental research. Furthermore, these chips have been used in drug development research initiatives including contagious and lethal disorders. Protein chips are made comprised of a support surface, such as a glass slide or microtitre plate, that aids in the capture of protein in use, and these molecules are then labelled and assembled in a dye of a certain colour and added to the array. Any interaction between them is then signalled and recorded for future experimentation.
Latin America Protein Chip Market Scope
|
Metrics |
Details |
|
CAGR |
18.1% |
|
Size Available for Years |
2021-2030 |
|
Forecast Period |
2023-2030 |
|
Data Availability |
Value (US$) |
|
Segments Covered |
Technology, Application, and End User |
|
Countries Covered |
Brazil, Argentina, Chile, Mexico and Rest of Latin America |
|
Largest Country |
Brazil |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report - Request for Sample
Market Drivers
Protein chips are being adopted at a rapid rate in the field of biomedical and biotechnology due to factors such as an increase in the percentage of geriatric people in Latin America, the prevalence of target diseases, rapid research and development in protein arrays, the study of protein interactions, and the growing demand for early detection of cancer. Furthermore, the emergence of many novel applications includes medical uses, protein chips such as DNA microarrays, protein-small molecule interactions, and the desire for individualized medications.
The demand for protein chips rose during the health crisis caused by the unique COVID-19 pandemic in 2020-2022 owing to their capacity to detect hazardous biological substances and provide quick diagnosis of many ailments. The finding of markers and medicines is a typical use of proteomics. Moreover, factors such as growing usage in cancer detection and treatment, as well as fast technology breakthroughs like sequence engineering, genome studies, and others, have a significant impact on the market.
Latin America Protein Chip Market Segmentation
The Latin America Protein Chip Market is segmented based on technology, application, and end user.
By Technology, the analytical microarrays segment is estimated to provide the bulk of revenue over the forecast period. Due to the multiple benefits offered, analytical microarrays are widely used in a range of applications, such as assessing a complex combination of proteins to find specificities, binding affinities, and levels of protein expression. In this method, a range of antibodies, aptamers, or affibodies are placed on a glass microscope slide, and the targeted protein is recognized in a sandwich assay format utilizing direct labelling or a reporter antibody.
Geographical Analysis
Geographically, Brazil is expected to have the greatest CAGR in revenue over the projected period, owing to rising demand for microarray testing and the region's sizable elderly population. Strict rules controlling the pharmaceutical and allied sectors in numerous developed nations, as well as the efficacy of quality control and quality assurance procedures, are also driving the regional market. As a consequence, this area has stayed at the forefront of growth potential and innovations in the field of protein chips throughout the years.
Mexico is expected to account for a substantial portion of revenue in the next years, owing to the existence of various pharmaceutical and bio-science firms, skilled labour, and several notable participants in the area of protein chips. Furthermore, the fast development of protein chips and the low cost of tests are expected to boost market growth.
Competitive Landscape
The major players in the Latin America Protein Chip Market are SEQUENOM, Inc., Sigma Aldrich Corporation, Affymetrix, Inc., EMD Millipore, Illumina, Inc., Life Technologies Corporation, and Agilent Technologies.
